Author:
Kris Mark G.,Tonato Maurizio,Bria Emilio,Ballatori Enzo,Espersen Birgitte,Herrstedt Jørn,Rittenberg Cynthia,Einhorn Lawrence H.,Grunberg Steven,Saito Mitsue,Morrow Gary,Hesketh Paul
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Aapro M, Selak M, Lichinitser D, Santini A, Macciocchi A, Klinik A, Blokhin NN (2003) Palonosetron (PALO) is more effective than ondansetron (OND) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC): Results of a Phase III trial. Proc Am Soc Clin Oncol 22:726
2. Aapro MS, Grunberg SM, Manikhas GM, Olivares G, Suarez T, Tjulandin SA, Bertoli LF, Yunus F, Morrica B, Lordick F, Macciocchi A (2006) A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 17:1441–1449
3. Andrews PLR, Davis CJ (1993) The mechanism of emesis induced by anti-cancer therapies. In: Andrews PLR, Sanger GJ (eds) Emesis in anticancer therapy mechanisms and treatment. Chapman & Hall, London, pp 14–17
4. Beck TM, Hesketh PJ, Madajewicz S, Navari RM, Pendergrass K, Lester EP, Kish JA, Murphy WK, Hainsworth JD, Gandara DR, Bricker LJ, Keller AM, Mortimer J, Galvin DV, House KW, Bryson JC (1992) Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. J Clin Oncol 10:1969–1975
5. Blum RA, Majumdar A, McCrea J et al (2003) Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects. Clin Ther 25:1407–1419
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献